Loading your experience...
Preparing something amazing for you

5.9
@Auritec1
Serial Biotech Entrepreneur
AI Fluency Score
5.9/10
Assessed 11/26/2025
Velocity
Generated 12/1/2025
Tom Smith is a serial biotech entrepreneur with over two years of hands-on AI experience, now applying these tools to regulatory submissions, clinical trial design, and pharmaceutical licensing. He builds custom Claude Skills for document workflows, understands where AI pattern-matching breaks down in specialized domains, and catches subtle judgment failures that less experienced users miss entirely.
What makes Tom's trajectory compelling: he's combining deep biotech expertise with rapidly evolving AI capabilities, learning new techniques monthly and using AI to improve his own AI usage. At 75, he's lived through the PC revolution, the internet revolution, and is now positioning his seven-figure company for the AI era—with clear eyes about both the opportunities and the limitations.
Moorfields trained. Last academic appointment Harvard.
1990-2001 Control Delivery Systems Inc now Eyepoint (NASDAQ EYPT) market cap: $1.2B
Auritec Pharmaceuticals 2002- Continuous NIH funding 2006-